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Abstract
Most genome-wide association studies have been conducted in European individuals, even though 
most genetic variation in humans is seen only in non-European samples. To search for novel loci 
associated with blood lipid levels and clarify the mechanism of action at previously identified lipid 
loci, we examined protein-coding genetic variants in 47,532 East Asian individuals using an 
exome array. We identified 255 variants at 41 loci reaching chip-wide significance, including 3 
novel loci and 14 East Asian-specific coding variant associations. After meta-analysis with > 
300,000 European samples, we identified an additional 9 novel loci. The same 16 genes were 
identified by the protein-altering variants in both East Asians and Europeans, likely pointing to the 
functional genes. Our data demonstrate that most of the low-frequency or rare coding variants 
associated with lipids are population-specific, and that examining genomic data across diverse 
ancestries may facilitate the identification of functional genes at associated loci.
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Genome-wide association studies (GWAS) have revealed over 175 genetic loci contributing 
to lipid levels1–6, which are heritable risk factors for cardiovascular disease, fatty liver 
disease, age-related macular degeneration and type 2 diabetes7–9. However, most of the 
published lipid-associated variants fall in non-protein-coding regions of the genome, are 
without obvious biological significance, and explain only a small fraction of the heritability 
of lipid levels. The examination of low frequency and potentially functional variants, poorly 
captured by standard GWAS arrays, has the potential to pinpoint causal variants and genes 
for follow-up and functional analyses, therefore promoting translation of the finding of 
genetic studies into new therapeutic targets. For example, low-frequency coding variants in 
PCSK9 lower plasma low density lipoprotein cholesterol (LDL-C), reduce risk of coronary 
artery disease (CAD), and have prompted the development of a new class of therapeutics10. 
Thus, we investigated the effect on lipid levels of the rare and low-frequency variants in the 
coding portion of the genome in an East Asian population, which has not been as extensively 
studied as the European population11–13.
We performed a meta-analysis of exome-wide association studies of blood lipid levels (high 
density lipoprotein cholesterol [HDL-C], LDL-C, triglycerides [TG], and total cholesterol 
[TC]) in a total of 47,532 East Asian samples that were genotyped using an exome array. We 
further integrated the exome array data for plasma lipids in over 300,000 individuals, 
primarily European ancestry (84%), conducted by the Global Lipids Genetics Consortium 
(GLGC). We aimed to determine whether novel or population-specific variants and genes 
influencing lipid levels could be identified in East Asian and multi-ancestry meta-analysis. 
Secondly, we aimed to determine if the protein-altering variants located in known lipid loci 
explained the association signal or were independent evidence of functional genes. And 
lastly, we examined whether exome data would implicate the same putatively functional 
genes in European and East Asian ancestries at lipid loci.
Results
To improve the coverage for the low frequency variants in Asian populations and follow up 
various GWAS variants, approximately 60K custom content variants were added to the 
standard exome array. Among 319,272 variants passing quality control, 204,408 (64.0%) 
were polymorphic in the East Asian individuals, of which about 25% (n = 50,126) were 
from the custom content. Approximately 76.1% (n=155,566) of the polymorphic variants are 
annotated as nonsynonymous or loss of function (stop-gain, stop-loss and splice variants) 
(Supplementary Table 1). By determining the proportion of variants observed in ExAC East 
Asian samples (n = 4,327 individuals) that were successfully genotyped by the array, we 
estimated that the exome array captured a large fraction of common and low-frequency 
coding variants (71.15% and 72.59% for variants with minor allele frequency (MAF) >5% 
and MAF = 1–5%, respectively). Among rare coding variants identified in ExAC sequenced 
individuals, 59.91% (MAF = 0.1–1%) and 19.92% (two or more copies) were captured by 
the array. Therefore, the array provided good coverage for low-frequency and moderate 
coverage for rare coding variants in East Asians. In addition, we examined 76K polymorphic 
coding variants that were not available or monomorphic in ExAC East Asian samples.
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Discovery of novel variants associated with lipid levels
Our analysis identified three study-wide significant variants in three novel loci in East 
Asians, located at least 1 megabase from previously reported GWAS signals of lipid levels 
(Table 1). These include rs4377290 in ACVR1C (TC, P = 4.69 × 10−8), rs7901016 in MCU 
(LDL-C, P = 5.12 × 10−9), and the missense variant rs4883263 (encoding p.Ile342Val) in 
CD163 (HDL-C, P = 5.24 × 10−11). Each of these three variants demonstrated evidence for 
association (P = 1.80 × 10−3~ 6.68 × 10−5) in over 300,000 GLGC individuals.
Summary of association results
We assessed association of 110,986 polymorphic variants that had at least 20 minor alleles in 
47,532 East Asian samples. Overall, we detected 255 variants (including 51 coding variants) 
at 41 loci that reached exome-wide significant association with one or more lipid trait (P < 
4.5× 10−7), of which 3 loci have not been previously reported (Figure 1). Collectively, the 
overall variance in each lipid trait explained by exome-wide significant variants in East 
Asian samples was 5.97% for TC, 6.20% for LDL-C, 6.93 % for HDL-C, and 6.89% for TG 
levels, respectively, of which 3.22 %, 4.77%, 3.35% and 3.86% can be attributed to coding 
variants (Figure 2). Our results also showed that additional 7 known loci were associated 
with lipid levels at suggestive significance (P < 4.46 × 10−6, Bonferroni correction of 11,215 
variants) (Supplementary table 2), and that, taken together they increased the trait variance 
explained to 6.08%~7.20%.
Evaluation of known lipid signals
Among the 38 previously established lipid loci that reached significance, we identified a 
more significant candidate variant at 14 loci (Supplementary Table 3 and Figure 1), where 
the initially reported GWAS index variants showed no significant associations or were 
independent of previously identified associations in European populations (r2 < 0.02) 
(APOB and APOE), demonstrating allelic heterogeneity between East Asian and European 
ancestries. The lead variants in the remaining 24 loci were the same as or strongly related (r2 
> 0.69) to the reported GWAS index variants from previous studies in primarily European 
samples. Sequential conditional analyses revealed that 12 loci with evidence of association 
exhibited two or more significant signals (Supplementary Table 4). For example, a novel 
missense variant (rs2075260, encoding p.Val2141Ile) at ACACB was detected and largely 
independent of the originally reported GWAS index rs7134594 at MVK (r2 = 0.01)2, 
representing novel association not previously reported. The GWAS index rs7134594 could 
be explained by another missense variant (rs9593 p.Met239Lys) at MMAB (conditional P = 
0.73).
For gene-base analysis, nine genes (PCSK9, EVI5, HMGCR, CD36, APOA1, PCSK7, 
CETP, LDLR and PPARA) reached gene-based significance (P < 2.8 × 10−6) with lipid 
levels (Supplementary Figure 1 and Supplementary Table 5), however, no new genes were 
identified by gene-based analyses that weren’t already highlighted by single variant tests.
Putative functional coding variants at the known loci
Identifying coding variants in known loci has the potential to help pinpoint causal genes. We 
observed that the protein-altering variants are more likely to have strong effect sizes on lipid 
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levels (Figure 3 and Supplementary Table 6), compared to the non-coding variants 
significantly associated with lipid levels. Ten coding variants in eight genes showed strong 
effects on lipid levels (beta range from 0.20 to 1.17 SD units), and 8 were low-frequency or 
rare variants (MAF < 3%). We next sought to quantify what proportion of GWAS loci might 
be due to a protein-altering variant, implicating a candidate functional gene. We make the 
reasonably well-supported assumption that a protein-altering variant, if the top signal, 
explains the signal, or is independent of the original signal, is the most likely causal variant 
for each region14–16. Among the 38 known loci showing association evidence at study-wide 
significance, 12 loci harbored a protein-altering variant that exhibited strongest association 
with lipid levels, while 4 loci have a protein-altering variant that was not the top signal but 
could explain the association of the reported index variant (Supplementary Table 7 and 
Figure 1). In 8 of these 16 loci (PCSK9, EVI5, CD36, MMAB, ALDH2, SLC12A4, LDLR, 
and PPARA), the previously identified lead variants in European populations did not reach 
exome-wide significance. In the remaining 8 loci (GCKR, MLXIPL, HNF1A, LPL, ABO, 
GPAM, PMFBP1, and TM6SF2), the GWAS index variant in each locus (P values range 
from 4.86×10−8 to 1.26×10−62) is in strong LD with the corresponding protein-altering 
variant (r2 > 0.68) and does not remain significant after accounting for the effect of the 
protein-altering variant (conditional P values > 0.01), suggesting that the index variant might 
act as a proxy for the functional protein-altering variant. Together, 42.1% (16/38) of loci 
appear to have a protein-altering variant that could account for the original association 
signal. In addition, we identified 15 protein-altering variants in 9 genes (APOB, HMGCR, 
ABCA1, APOA1-APOA5, ACACB, CETP, PKD1L3, LIPG, and APOE) that were 
independent of the original signal but may highlight functional genes in the region. All of 
these putative functional variants may point to functional candidate genes: either well-
established causal genes (such as the genes that cause Mendelian dyslipidemias 
(Supplementary Table 8)) or to potential new candidate genes (MMAB, ACACB, SLC12A4, 
and PMFBP1). In total, the 31 protein-altering variants in the known loci may point to 25 
candidate functional lipid genes.
Association with coronary artery disease
To further evaluate whether the novel variants and putative functional variants in known 
regions identified in our samples also influenced CAD risk, we tested for association in 
28,899 Chinese individuals with and without coronary disease (9,661 CAD cases and 18,558 
controls) and in the largest publicly available CAD GWAS analyses 
(CARDIoGRAMplusC4D) of ~185,000 CAD cases and controls17 (Supplementary Table 9). 
For the novel non-coding variant near MCU (rs7901016), the C allele associated with lower 
LDL-C was similarly associated with reduced risk for CAD in Chinese samples (OR = 0.94, 
95% CI = 0.90–0.98, P = 2.8×10−3) and CARDIoGRAMplusC4D (OR = 0.94, 95% CI = 
0.91–0.98, P = 4.55×10−4). Among the 31 putative functional coding variants in the known 
regions, all the 20 non-HDL-C related variants displayed a consistent direction of effect 
between lipid traits and CAD. 15 out of 20 showed nominal significance (P < 0.05) in 
Chinese or CARDIoGRAMplusC4D CAD data, whereas 7 variants in PCSK9, APOB, 
LDLR, APOE, HNF1A, and APOA5 displayed significant associations even after 
accounting for multiple testing (P-value range from 5.95×10−4 to 8.17×10−11 < 0.05/31). In 
particular, nearly all of the LDL-associated coding variants demonstrated association with 
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CAD, and the strengths of effect on CAD risk and LDL-C were highly correlated (r2 = 0.78, 
P = 3.3× 10−4, Supplementary Figure 2).
Novel loci identified by East Asian and GLGC samples
An exome-wide association screen for plasma lipids in >300,000 individuals genotyped by 
the exome array was conducted in parallel by the Global Lipids Genetics Consortium. The 
majorities (84%) of the participants were of European ancestry, and only 2.3% were East 
Asian. We further carried out large-scale trans-ancestry meta-analysis in our East Asian and 
GLGC samples, being careful to include overlapping samples only once, to seek both novel 
and population-specific genetic variants for lipid levels.
In the combined GLGC and East Asian samples, 9 additional variants showed significant 
associations (P < 2.1 × 10−7, Bonferroni correction of 242,289 variants analyzed in GLGC) 
with at least one lipid trait, that were not significant in either the East Asian or GLGC 
analyses. All of them are common (MAF > 0.05 in both East Asian and GLGC), including 4 
coding variants (Table 2 and Supplementary Figure 3): FAM114A2 (p.Gly122Ser, HDL-C, P 
= 1.74 × 10−7), MGAT1 (p.Leu435Pro, HDL-C, P = 9.36 × 10−8), ASCC3 (p.Leu146Phe, 
LDL-C, P = 5.84 × 10−8, TC, P = 5.22 × 10−9), PLCE1 (p.Arg1575Pro, TC, P = 9.92 × 
10−8).
Joint analysis of the novel signals with additional samples
To strengthen support for association, we performed in silico replication of significant 
variants in three additional independent genome-wide datasets, comprising a combined total 
of ~160,000 individuals from the Nord-Trøndelag Health Study (HUNT)18, GLGC GWAS 
samples2, and Chinese lipids GWAS study19. We found that the associations of 12 novel 
variants became more significant and reached genome-wide significance in the joint analysis 
(P values range from 2.99×10−8 to 7.62×10−15) (Supplementary Table 10).
Coding variants point to the same genes across ancestries
We further evaluated whether these variants identified in East Asian were also defined as 
putative functional variants in GLGC samples (Supplementary Table 11). We found that both 
East Asian and GLGC samples pointed to the same nine functional genes, but had different 
associated variants in each ancestry (Table 3). The eight coding variants (MAF range from 
0.004% to 15.9%) at PCSK9, CD36, ABCA1, CETP, PMFBP1, LIPG, LDLR, and PPARA 
identified by GLGC showed lower minor allele frequencies (MAF range from 0 to 2.57%) in 
the East Asian samples and, thus, displayed no significance or only suggestive significance 
(CETP). Conversely, the coding variants at PCSK9, APOB, CD36, CETP, LDLR and 
PPARA identified in East Asian (MAF range from 0.094% to 12.45%) also had lower minor 
allele frequencies in GLGC (MAF range from 0.001% to 0.20%). In addition, the same 
putatively functional coding variants and genes at seven loci (GCKR, MLXIPL, LPL, 
GPAM, HNF1A, TM6SF2, and APOE) were identified in both East Asian and GLGC 
samples, with similar common minor allele frequencies (Table 4).
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East Asian-specific association signals
We next attempted to identify variants that were associated with lipids in East Asian samples 
only. Within the known lipid loci, 363 independent variants were identified by sequential 
conditional analyses in GLGC exome-wide association studies (Supplementary Table 11). 
After conditioning on the independent variants in the corresponding loci, we identified 14 
independent coding variant associations at 11 loci in East Asian samples with conditional P 
values < 4.5 × 10−7 (Table 5, Figure 1 and 3). Interestingly, all 14 East Asian-specific 
variants are included in the list of the putative functional variants we identified. Eight of 
these loci (EVI5, APOB, HMGCR, CD36, APOA1, CETP, LDLR, and PPARA) harbored at 
least one low-frequency or rare independent coding variant (MAF range from 4.21% to 
0.03%). All of these variants are either monomorphic or have a frequency at least 1 order of 
magnitude lower in Europeans and, thus, showed only suggestive significance in ~ 300,000 
GLGC individuals.
Discussion
This study represents the largest discovery effort for coding variation that influences lipid 
levels in the East Asian population, enabling us to systemically evaluate protein-altering 
variants that identify candidate functional genes. Meta-analyses in East Asian and multi-
ancestry samples using an exome-chip genotyping array identified twelve novel loci, five of 
which harbored non-synonymous variants. In the 38 known loci that were replicated, we 
identified 31 protein-altering variants that likely point to 25 functional lipid genes. 
Moreover, the same 16 putative functional genes were identified by significant association 
with protein-altering variants in both European and East Asian samples--at 9 of those genes 
by identifying independent protein-altering variants in the two ancestries.
Among the novel genetic loci identified, several have been implicated in cardiovascular and 
metabolic phenotypes, which may provide mechanistic insight into the regulation of lipid 
levels and potential targets for treatments. The significant novel variant associated with both 
lipids and CAD is located in intron of MCU. MCU encodes mitochondrial inner membrane 
calcium uniporter that mediates calcium uptake into mitochondria. It has been found that 
mitochondrial calcium plays an important role in the regulation of metabolism in the heart20. 
CD163 encodes a macrophage specific receptor involved in the clearance and endocytosis of 
hemoglobin-haptoglobin complexes by macrophages. Soluble CD163 was recently proposed 
as a biomarker of the well-known variables metabolic syndrome, including HDL-
cholesterol21. ACVR1C encodes activin receptor-like kinase 7 (ALK7), one of the type I 
transforming growth factor-β receptors. ALK7 has recently been demonstrated to play an 
important role in the maintenance of metabolic homeostasis22. ALK7 is highly expressed in 
adipose tissue of humans and is correlated with body fat and lipids. The ALK7 dysfunction 
could cause increased lipolysis in adipocytes and leads to decreased fat accumulation. 
MGAT1 encodes Mannosyl (Alpha-1,3-)-Glycoprotein Beta-1,2-N-
Acetylglucosaminyltransferase, which is involved in the synthesis of protein-bound and 
lipid-bound oligosaccharides. It has been found that the variant in MGAT1 was associated 
with body weight and obesity23. Of note, CD163 and PDGFC were also found to be 
associated with lipid levels by the East Asian lipids GWAS meta-analysis since our 
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manuscript was submitted24. To further clarify the possible transcriptional mechanisms 
underlying the identified loci in associations with lipids, we investigated the relationships of 
the novel variants and proxies with expression quantitative trait loci (eQTLs) using the 
GTEx eQTL browser. Significant cis-eQTLs effects in human tissues were found at five loci 
at a significance of P < 4.5 × 10−7 (Supplementary Table 12). We further predicted 
putatively regulatory variants in seven novel noncoding regions in 81 cell type lines using 
deltaSVM scores25, and found that the variants in PDGFC, LOC100996634, and MCU had 
high regulatory potential with extreme deltaSVM scores greater than 10 in absolute value 
(Supplementary Figure 4).
Our data provided a more comprehensive understanding of the genetic architecture of lipid 
susceptibility by discovering novel lipid genes and revealing allelic heterogeneity across 
different ancestry populations. We detected multiple independent association signals or new 
lead variants in known lipid-associated loci that frequently displayed no or moderate linkage 
disequilibrium (LD) with the corresponding GWAS index variants in European populations. 
Specially, we identified 14 East Asian-specific variants that could not be explained by all the 
independent variants in the corresponding loci identified by GLGC samples. Our study 
demonstrated the benefits of distinct LD patterns between ancestry groups in dissecting 
validated loci. We also found substantial inter-ancestry differences in the identification of 
rare coding variants across populations, which may have been subjected to natural selection 
during human evolution or genetic drift. All the low-frequency or rare functional coding 
variants identified in East Asians (MAF range from 0.03% to 4.21%) appeared to be 
population-specific, and were monomorphic or not present in 1000 Genomes European 
individuals, this allelic heterogeneity across different ancestry populations have been partly 
reported6,11. However, we observed that these rare variants were not monomorphic in over 
300,000 GLGC individuals, but had 15 to 160-fold lower frequencies (MAF range from 
0.001% to 0.15%) in Europeans than East-Asians (Supplementary Table 13 and 
Supplementary Figure 5), with little power to detect association in Europeans. Similarly, the 
low-frequency and rare coding variants identified in GLGC samples were extremely rare or 
monomorphic in East Asian samples (Supplementary Figure 6 and Supplementary Table 11). 
Overall, our finding demonstrated that rare and low frequency coding variants are more 
likely to be population-specific, which underscores the value of discovering ancestry-
specific rare variants in diverse populations, particularly for low frequency variation.
Since most GWAS index variants are located in non-coding regions, the identification of 
associated protein-coding variants may allow us to prioritize functional genes and variation. 
Among the 38 known loci that reached chip-wide significance in our data, coding variants at 
16 loci (42.1%) were found to completely account for the original association signal. At an 
additional 9 loci, an independent protein-altering variant indicated a likely functional gene. 
The coding variants are more likely to have consistent effect sizes across ethnic groups 
compared to non-coding variants. For the GWAS index variants that could not be replicated 
in East Asian samples, the effect sizes were poorly correlated with those observed in 
Europeans. In contrast, the effect sizes of the putatively-functional coding variants in the 
same loci are strongly related across ethnic groups (Supplementary Figure 7). Trans-ancestry 
comparison provided additional credible evidence to support the same 16 genes as putative 
functional genes. The functional genes pointed to by coding variants are either well-known 
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genes or genes with previously unknown roles in lipid metabolism (such as GPAM and 
PMFBP1), which may be good candidates for functional assessment. More importantly, we 
found the effects of these putative functional coding variants on LDL cholesterol, 
triglyceride, and total cholesterol were highly correlated with the effect on CAD, but the 
effect on HDL cholesterol levels were not correlated with CAD. Our findings are consistent 
with the recent genetic studies that both LDL cholesterol and triglyceride levels but not HDL 
cholesterol levels are causally related to CAD risk26–29.
This large-scale exome wide association study allowed us to detect a larger number of low-
frequency and rare variants, 30% of which were not polymorphic in the previous exome-
wide study involving 12,685 Chinese individuals11. Nonetheless, the exome array offered 
moderate coverage for rare variants observed in ExAC East Asian samples. Power 
calculations indicated that the available sample size provided 80% power to detect variants 
with effect size of 0.27 s.d. and MAF as low as 0.5% at P < 4.5 × 10−7. However, we had 
considerably less power to evaluate extremely rare variants (MAF < 0.1%). Studies in larger 
sample sizes and of sequenced samples are therefore needed to fully investigate associations 
of rare variants with lipid levels.
In conclusion, we identified 12 new loci associated with lipid levels. We also identified 
coding variants that highlight 25 likely functional genes at previously known loci, including 
several with previously undiscovered roles in lipids. We also found an abundance of 
population specific coding variant associations that underlie lipid traits, highlighting the 
importance of including individuals of diverse ancestry background. At the same time, our 
data demonstrate that integrating genomic data across diverse ancestry groups may enable us 
to determine functional variants and genes for further functional study.
Methods
Study cohorts
Twenty three studies including both population-based studies and case-control studies of 
coronary artery disease (CAD) and type 2 diabetes (T2D) were genotyped with the Illumina 
HumanExome array resulting in a total of 47,532 participants, all of whom were of East 
Asian ancestry (Supplementary Table 14). All participants provided written informed 
consent, and ethics approval for their data generation and analyses was individually obtained 
for each contributing study. The relevant human genetic data was also approved by Ministry 
of Science and Technology of China. For GLGC exome study, the studies contributed 
association results for exome chip genotypes and plasma lipid levels (Supplementary notes 
and Supplementary Table 15).
Phenotypes
For most East-Asian subjects (83%), TC, HDL-C, and TG were measured at > 8 hours of 
fasting. LDL-C levels were directly measured in 18 studies (88% of total study individuals) 
and were estimated using the Friedewald formula in the remaining studies, with missing 
values assigned to individuals with triglycerides >400 mg/dl. We adjusted the TC values for 
individuals on lipid-lowering medication by replacing their TC values by TC/0.8 with lipid 
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medication status available. If measured LDL-C was available in a study, the treated LDL-C 
value was divided by 0.7. No adjustment for individuals using medication was made for 
HDL-C and TG.
Exome array genotyping and quality control
All study participants were genotyped on the HumanExome Bead-Chip (Illumina), and most 
cohorts (83%) also included the custom Asian Vanderbilt content. This custom content was 
added to the standard Illumina HumanExome BeadChip to improve the coverage of low 
frequency variants in Asian populations. The variants were selected from 1077 (581 Chinese 
women and 496 Singapore Chinese) whole exome sequenced East Asian samples generously 
provided by Wei Zheng and Jianjun Liu30. Additional approximately 29K common variants 
were added to the array including previously identified GWAS variants selected from the 
GWAS catalogue. Genotype calling was performed with GenTrain version 2.0 in 
GenomeStudio V2011.1 (Illumina) in combination with zCall version 2.231. Within each 
study, individuals with low genotype completion rates, individuals expressing gender 
mismatches or a high level of heterozygosity, and related individuals, and PCA outliers were 
excluded from further analysis (Supplementary Table 16). In addition, variants that did not 
meet the 95% or 98% genotyping threshold or showed deviation from the Hardy-Weinberg 
equilibrium were removed.
Statistical analyses
Within each cohort, HDL-C, LDL-C, TG and TC measurements were transformed using the 
inverse normal distribution after adjustment of each trait for age, age2, and study-specific 
covariates, including principal components in order to account for population structure. In 
studies ascertained on diabetes or cardiovascular disease status, cases and controls were 
analyzed separately.
We performed both single variant and gene-level association tests. Single variant analyses in 
each cohort were carried out using either RAREMETALWORKER or RVTESTS32, both of 
which generate single variant score statistics and their covariance matrix between single 
marker statistics. The test statistics, as visualized in a quantile–quantile plot, appeared well-
calibrated (Supplementary Figure 8). Gene-based tests were restricted to variants that were 
predicted to alter the coding sequence of the gene product (defined as missense, stop-gain, 
stop-loss, or splice-site variants) in order to enhance the likelihood of identifying causal 
variants and to reduce the multiple testing burden. For each trait, we ran four gene-based 
tests: a variable threshold burden test with a MAF cutoff of <5% or <1% and a sequence 
kernel association test (SKAT) with a MAF cutoff of <5% or <1%. Next, the meta-analyses 
of single variant and gene-level association tests were performed using RAREMETALS33 
for HDL-C, LDL-C, TC and TG. For single variants, we applied a significance threshold of 
P < 4.5 × 10−7, corresponding to a Bonferroni correction for 110,986 polymorphic variants 
that had at least 20 minor alleles. For gene-level tests, we used a significance threshold of P 
< 2.8 × 10−6, corresponding to a Bonferroni correction for 17,614 gene-level tests.
To identify putative functional coding variants accounting for the effects at known lipid loci, 
we performed reciprocal conditional analyses to control for the effects of known lipid 
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GWAS or coding variants. Loci where the initial lead variant had conditional P > 0.01 were 
considered to be explained by the variants used in the conditional analyses. To dissect East 
Asian-specific association signals in the reported loci, we also performed conditional 
association analysis for variants within 1MB of each locus using covariance matrices 
between single variant association statistics. Details of the methods can be found in Liu et 
al32. To evaluate whether two or more independent association signals, we performed 
sequential conditional association analyses using the lead variant at each locus as a covariate 
until results after conditional analysis were no longer significant (P > 4.5× 10−7). We 
estimated the linkage disequilibrium (LD) metric r2 using the cohort-combined variants and 
LD matrices. LD for variants not included on the exome array was estimated from the 1000 
Genomes Project East Asian individuals.
To further assess whether the identified functional coding variants also relate to coronary 
artery disease (CAD), we tested their associations with CAD in PUUMA-MI11, HKU-TRS, 
HuCAD34, and two GWAS samples35 (the Beijing Atherosclerosis Study (BAS) and the 
China Atherosclerosis Study (CAS)) involving 9,661 CAD cases and 18,558 controls. The 
effect estimates and s.e. were meta-analysed using METAL by the fixed-effect inverse-
variance method36. We also looked up the CAD association in the largest publicly available 
CAD GWAS analyses (CARDIoGRAMplusC4D) of ~185,000 CAD cases and controls17.
In silico Replication Samples
The in silico replication study was conducted using additional independent individuals of 
European ancestry from the HUNT study18 and GLGC GWAS2, and Chinese subjects from 
Chinese lipids GWAS19. HUNT is a population-based cohort of 62,168 individuals with 
genome-wide genotypes (Illumina Human CoreExome), imputation from the Haplotype 
Reference Consortium panel, and non-fasting lipid phenotypes. The Chinese lipids GWAS 
was a meta-analysis consisting of over 13,000 Han Chinese who underwent standardized 
collection of blood lipid measurements in five independent genome wide association studies. 
These studies included the China Atherosclerosis Study (CAS), the Beijing Atherosclerosis 
Study (BAS), Genetic Epidemiology Network of Salt-Sensitivity (GenSalt) study37, and the 
China Atherosclerosis Study phase II (CAS-II).
Heritability and proportion of variance explained estimates
We estimate the proportion of variance explained by the set of independently associated 
variants. Joint effects of variants in a locus were approximated by β JOINT = VMETA
−1 U META, 
where UN⃗ETA is single variant score statistics and VMETA
−1  is the covariance matrix between 
them. Covariance between single variant genetic effects were approximated by the inverse of 
the variance-covariance matrix of score statistics, i.e. VMETA
−1 . The explained phenotype 
variance by independently associated variants in a locus is given by β joint
T
cov(G)β JOINT.
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Variants were annotated as missense, splice, stop-gain/loss, synonymous or noncoding using 
ANNOVAR (version 2012-05-25)38. Variant identifiers and chromosomal positions are listed 
with respect to the hg19 genome build.
DeltaSVM analysis
DeltaSVM uses a gapped k-mer support vector machine to estimate the effect of a variant in 
a cell-type-specific manner25. Precomputed weights were available from a total of 222 
ENCODE DHS samples—99 from the Duke University (Duke) set and 123 from the 
University of Washington (UW) set39. For the current study, genetic variants were scored for 
deltaSVM in 81 cell lines from four tissues (blood, blood vessel, heart and liver). For each of 
the seven novel noncoding regions, all proxies (r2 > 0.8) were identified using data from 
1000 genome.
Data Availability
Summary statistics have been made available for download from http://csg.sph.umich.edu/
abecasis/public/lipids2017EastAsian. Additional supporting data are provided in the 
supplementary material.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Manhattan plot of exome-wide association results in 47,532 East Asians
Manhattan plot showing −log10 P of the variants for LDL-C, HDL-C, TC and TG. Signals 
with exome-wide levels of significance (horizontal dash line; P < 4.5×10−7) are highlighted 
and the previously reported GWAS lead variant of each region are labeled separately in 
diamond. East Asian-specific variants are defined as the variants with conditional P values 
reaching exome-wide significance after conditioning on all independent variants in the 
corresponding loci identified by GLGC exome-wide association studies.
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Figure 2. Proportion of total trait variance explained by the significant and coding variants
The variances explained by all the variants reaching exome-wide significance (P < 4.5 × 
10−7), and together with the variants at suggestive significance (P < 4.46 × 10−6) are 
presented with light blue and purple bars, respectively. The proportions of variance 
explained by the corresponding protein-altering variants are represented by dark blue and 
purple bars, respectively. The proportions of variance explained by GWAS index variants are 
represented by yellow bars.
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Figure 3. Effect Size vs. Allele Frequency for variants associated with blood lipids at exome-wide 
significance
The protein-altering variants are shown in red in comparison to the non-coding variants 
shown in black. East Asian-specific protein-altering variants are labeled in diamond. The 
variants shown in triangle, PCSK9 (p.Arg93Cys) and APOA5 (p.Gly185Cys), have 
extremely rare minor allele frequencies in Europeans, although they do not display 
population-specific association. The protein-altering variants show strong effects on lipid 
levels (beta > 0.20 SD units) are highlighted. Estimated power curves are shown (as dashed 
lines) for the minimum standardized effect sizes (in s.d. units) that could be identified for a 
given effect-allele frequency with 10% (purple), 50% (green) and 80% (blue) power, 
assuming sample size 47,532 and alpha level 4.5 × 10−7.
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